Application Nr Approved Date Route Status External Links
ANDA078723 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Montelukast Sodium Is A Leukotriene Receptor Antagonist Indicated For: Prophylaxis And Chronic Treatment Of Asthma In Patients 2 Years Of Age And Older ( 1.1 ). Acute Prevention Of Exercise-Induced Bronchoconstriction (Eib) In Patients 6 Years Of Age And Older ( 1.2 ). Relief Of Symptoms Of Allergic Rhinitis (Ar): Seasonal Allergic Rhinitis (Sar) In Patients 2 Years Of Age And Older, And Perennial Allergic Rhinitis (Par) In Patients 2 Years Of Age And Older ( 1.3 ). 1.1 Asthma Montelukast Sodium Is Indicated For The Prophylaxis And Chronic Treatment Of Asthma In Adults And Pediatric Patients 2 Years Of Age And Older. 1.2 Exercise-Induced Bronchoconstriction (Eib) Montelukast Sodium Is Indicated For Prevention Of Exercise-Induced Bronchoconstriction (Eib) In Patients 6 Years Of Age And Older. 1.3 Allergic Rhinitis Montelukast Sodium Is Indicated For The Relief Of Symptoms Of Seasonal Allergic Rhinitis In Patients 2 Years Of Age And Older And Perennial Allergic Rhinitis In Patients 2 Years Of Age And Older.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Montelukast Sodium MONTELUKAST SODIUM ZINC3831151

Comments